An imaging-guided core needle biopsy has been proven to be reliable and accurate for the diagnosis of both benign and malignant diseases of the breast, and has replaced surgical biopsy. However, the possibility of a false-negative biopsy still remains. Imaging-pathology correlation is of critical importance in imaging-guided breast biopsies to detect such a possible sampling error and avoid a d...

and nonpalpable breast lesions is a safe and effective alternative to fine-needle aspiration and needle-localized breast excisional biopsies (1, 2). It can reduce the need for a two-stage procedure and can improve the surgical and oncological outcomes (3). However, one disadvantage of this technique for sampling breast cancer is the possible seeding of malignant tumor cells along the needle tra...

Received February 26, 2007, from the Department of Radiology, Bronx Lebanon Hospital, Bronx, New York USA. Revision requested March 16, 2007. Revised manuscript accepted for publication March 26, 2007. Address correspondence to Helen Morehouse, MD, Department of Radiology, Bronx Lebanon Hospital, 1650 Grand Concourse, Bronx, NY 10457 USA. E-mail: [email protected] ome expertise as well as h...

We describe a side-firing fiber optic sensor based on near-infrared spectroscopy for guiding core needle biopsy diagnosis of breast cancer. The sensor is composed of three side firing optical fibers (two source fibers and one detection fiber), providing two source-detector separations. The entire assembly is inserted into a core biopsy needle, allowing for sampling to occur at the biopsy site. ...

BACKGROUND Like all breast imaging modalities MRI has limited specificity and the positive predictive value for lesions detected by MRI alone ranges between 15 and 50%. MRI guided procedures (needle biopsy, presurgical localisation) are mandatory for suspicious findings visible only at MRI, with potential influence on therapeutic decision. The aim of this retrospective study was to evaluate our...

OBJECTIVE In this study, we aimed to determine the need for biopsy in patients referred from other clinics for the performance of biopsy with the suspicion of breast cancer. MATERIALS AND METHODS 112 patients were included in the study. It was decided that their biopsies be performed following examinations in other clinics and they presented to the breast radiology unit of our hospital for a ...

Authors' conclusions The best available evidence suggests that breast symptoms are evaluated initially by clinical breast exam and imaging study, with supplemental studies when the diagnosis is unclear. There is no evidence to support modifying the workup of breast symptoms or mammographic abnormalities based on risk factors other than age. Strong evidence supports the necessity of performing e...

BACKGROUND Patients are increasingly presenting for outpatient breast biopsy while taking medically necessary antithrombotic therapy. Cessation of this medication prior to biopsy increases patients' risk of vascular complications. 
. OBJECTIVES This article evaluates the safety of performing core needle biopsies of the breast in patients without suspending prescription antithrombotic therapy....

A 65-year-old woman underwent core biopsy of a palpable left breast mass. This was a Nottingham grade II invasive ductal carcinoma with lymphovascular invasion. The tumor was ER/PR positive and Her-2/neu negative. The patient agreed to participate in the American College of Surgeon’s Oncology Group Z00100 trial. Two weeks later, the patient underwent a left breast lumpectomy, sentinel lymph nod...